1. Home
  2. ROIV
  3. ROIV News

Latest Roivant Sciences Ltd. (ROIV) News on November 6, 2025

Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints
ROIV

Insider Monkey

a month ago

Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints

Why Analysts Are Rethinking Roivant Sciences After Strong Phase 3 Results and Analyst Upgrades
ROIV

Simply Wall St.

a month ago

Why Analysts Are Rethinking Roivant Sciences After Strong Phase 3 Results and Analyst Upgrades

Vivek Ramaswamy's Bitcoin Play Just Got Bigger: This $1.3B Deal Could Signal Corporate Crypto's Next Phase
ROIV

Benzinga

a month ago

Vivek Ramaswamy's Bitcoin Play Just Got Bigger: This $1.3B Deal Could Signal Corporate Crypto's Next Phase

Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings
ROIV

Reuters

a month ago

Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings

Roivant Sciences (ROIV) Hits New All-Time High as Drug Candidate Clinical Trial Posts Impressive Results
ROIV

Insider Monkey

2 months ago

Roivant Sciences (ROIV) Hits New All-Time High as Drug Candidate Clinical Trial Posts Impressive Results

Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?
ROIV

Zacks

2 months ago

Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?

ROIV

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

ROIV

MT Newswires

2 months ago

Sector Update: Health Care

ROIV

MT Newswires

2 months ago

Roivant, Priovant Say Dermatomyositis Treatment Meets Main Goal in Phase 3 Study; Shares up Pre-Bell

Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)
ROIV

GlobeNewswire

2 months ago

Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)

Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock
ROIV

Barrons.com

2 months ago

Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock

Roivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent Challenges
ROIV

Simply Wall St.

2 months ago

Roivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent Challenges

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List
ROIV

GlobeNewswire

2 months ago

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List

Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat
ROIV

Insider Monkey

2 months ago

Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat

ROIV

MT Newswires

4 months ago

Roivant Sciences Insider Sold Shares Worth $1,145,000, According to a Recent SEC Filing

Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat
ROIV

Insider Monkey

4 months ago

Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat

ROIV

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 06/24/2025

Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
ROIV

GlobeNewswire

5 months ago

Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis
ROIV

GlobeNewswire

5 months ago

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis

ROIV

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 06/09/2025

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update
ROIV

GlobeNewswire

5 months ago

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update

What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings
ROIV

GuruFocus.com

5 months ago

What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025
ROIV

GlobeNewswire

6 months ago

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025

ROIV

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 05/09/2025

Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug
ROIV

Investor's Business Daily

7 months ago

Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
ROIV

GlobeNewswire

7 months ago

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose.
ROIV

Investor's Business Daily

8 months ago

Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose.

Roivant, Immunovant Succeed In Phase 3. But There's A Twist — And Shares Tumbled.
ROIV

Investor's Business Daily

8 months ago

Roivant, Immunovant Succeed In Phase 3. But There's A Twist — And Shares Tumbled.

Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
ROIV

GlobeNewswire

8 months ago

Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
ROIV

GlobeNewswire

8 months ago

Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
ROIV

GlobeNewswire

8 months ago

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

ROIV

GlobeNewswire

8 months ago

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board

Roivant Sciences price target lowered to $12 from $13 at BofA
ROIV

TipRanks

9 months ago

Roivant Sciences price target lowered to $12 from $13 at BofA

News Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) Forecasts
ROIV

Simply Wall St.

9 months ago

News Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) Forecasts

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update
ROIV

GlobeNewswire

9 months ago

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

What To Expect From Roivant Sciences Ltd (ROIV) Q3 2025 Earnings
ROIV

GuruFocus.com

9 months ago

What To Expect From Roivant Sciences Ltd (ROIV) Q3 2025 Earnings

Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care
ROIV

GlobeNewswire

9 months ago

Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
ROIV

GlobeNewswire

9 months ago

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025

Vivek Ramaswamy Open to Replacing JD Vance in Senate—if Offered
ROIV

The Wall Street Journal

10 months ago

Vivek Ramaswamy Open to Replacing JD Vance in Senate—if Offered

Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
ROIV

GlobeNewswire

a year ago

Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
ROIV

GlobeNewswire

a year ago

Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution
ROIV

Simply Wall St.

a year ago

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update
ROIV

GlobeNewswire

a year ago

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update

Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: What To Expect
ROIV

GuruFocus.com

a year ago

Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: What To Expect

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024
ROIV

GlobeNewswire

a year ago

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
ROIV

GlobeNewswire

a year ago

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

ROIV

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/27/2024

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
ROIV

GlobeNewswire

a year ago

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress
ROIV

GlobeNewswire

a year ago

Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress

Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator
ROIV

GlobeNewswire

a year ago

Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator

Roivant Provides Update on Graves’ Disease Development Program
ROIV

GlobeNewswire

a year ago

Roivant Provides Update on Graves’ Disease Development Program

The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy
ROIV

Yahoo Finance

a year ago

The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy

Shareholders In Roivant Sciences (NASDAQ:ROIV) Should Look Beyond Earnings For The Full Story
ROIV

Simply Wall St.

a year ago

Shareholders In Roivant Sciences (NASDAQ:ROIV) Should Look Beyond Earnings For The Full Story

Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
ROIV

GlobeNewswire

a year ago

Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update

Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024
ROIV

GlobeNewswire

a year ago

Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
ROIV

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
ROIV

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
ROIV

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
ROIV

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

ROIV

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
ROIV

AFP

a year ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
ROIV

Investor's Business Daily

a year ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
ROIV

The Wall Street Journal

a year ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
ROIV

GlobeNewswire

a year ago

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
ROIV

GlobeNewswire

a year ago

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024

Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain
ROIV

Simply Wall St.

2 years ago

Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
ROIV

GlobeNewswire

2 years ago

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million

Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck
ROIV

The Wall Street Journal

2 years ago

Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck

Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600
ROIV

PR Newswire

2 years ago

Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600

Roivant Sciences Third Quarter 2024 Earnings: Beats Expectations
ROIV

Simply Wall St.

2 years ago

Roivant Sciences Third Quarter 2024 Earnings: Beats Expectations

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
ROIV

GlobeNewswire

2 years ago

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update

Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares
ROIV

GuruFocus.com

2 years ago

Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares

Eastman's (EMN) Earnings and Sales Surpass Estimates in Q4
ROIV

Zacks

2 years ago

Eastman's (EMN) Earnings and Sales Surpass Estimates in Q4

Honeywell (HON) Q4 Earnings Match Estimates, Increase Y/Y
ROIV

Zacks

2 years ago

Honeywell (HON) Q4 Earnings Match Estimates, Increase Y/Y

KeyBank Teammates Discuss Best Practices for Homebuying and Programs to Help Make Home Ownership Easier
ROIV

ACCESSWIRE

2 years ago

KeyBank Teammates Discuss Best Practices for Homebuying and Programs to Help Make Home Ownership Easier

Byron Allen seeks television assets in Paramount bid - sources
ROIV

Reuters

2 years ago

Byron Allen seeks television assets in Paramount bid - sources

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024
ROIV

GlobeNewswire

2 years ago

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024

Tradeweb Markets (TW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ROIV

Zacks

2 years ago

Tradeweb Markets (TW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Community Resource Credit Union, CRCU Retirement and Investment Services, Partner With Trustage™
ROIV

GlobeNewswire

2 years ago

Community Resource Credit Union, CRCU Retirement and Investment Services, Partner With Trustage™

Shareholders Would Enjoy A Repeat Of Masco's (NYSE:MAS) Recent Growth In Returns
ROIV

Simply Wall St.

2 years ago

Shareholders Would Enjoy A Repeat Of Masco's (NYSE:MAS) Recent Growth In Returns

25 Best Dividend Growth Stocks to Buy and Hold in 2024
ROIV

Insider Monkey

2 years ago

25 Best Dividend Growth Stocks to Buy and Hold in 2024

Will Ralph Lauren (RL) Beat Estimates Again in Its Next Earnings Report?
ROIV

Zacks

2 years ago

Will Ralph Lauren (RL) Beat Estimates Again in Its Next Earnings Report?

Will Unum Group's (UNM) Beat Streak Continue in Q4 Earnings?
ROIV

Zacks

2 years ago

Will Unum Group's (UNM) Beat Streak Continue in Q4 Earnings?

ROIV

Morningstar Research

2 years ago

Analyst Report: American Airlines Group Inc.

ROIV

Thomson Reuters StreetEvents

2 years ago

Q4 2023 American Airlines Group Inc Earnings Call

E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know
ROIV

Zacks

2 years ago

E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know

American, United Soar On Earnings; Airline Stocks Gain Altitude; Alaskan Provides Boeing Update
ROIV

Investor's Business Daily

2 years ago

American, United Soar On Earnings; Airline Stocks Gain Altitude; Alaskan Provides Boeing Update

Zillow just raised its home price forecast, seeing a 3.7% jump in 2024, and it’s all because of ‘external factors’
ROIV

Fortune

2 years ago

Zillow just raised its home price forecast, seeing a 3.7% jump in 2024, and it’s all because of ‘external factors’

American Airlines misses out on cargo’s fourth-quarter bounce
ROIV

FreightWaves

2 years ago

American Airlines misses out on cargo’s fourth-quarter bounce

Returns At Ralph Lauren (NYSE:RL) Appear To Be Weighed Down
ROIV

Simply Wall St.

2 years ago

Returns At Ralph Lauren (NYSE:RL) Appear To Be Weighed Down

AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
ROIV

Zacks

2 years ago

AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment

22 Largest Clothing Companies by Market Cap in the World
ROIV

Insider Monkey

2 years ago

22 Largest Clothing Companies by Market Cap in the World

Aspen Technology Announces OPTIMIZE 24
ROIV

Business Wire

2 years ago

Aspen Technology Announces OPTIMIZE 24

Do You Think TransUnion’s (TRU) Earnings Growth Will Pick Up?
ROIV

Insider Monkey

2 years ago

Do You Think TransUnion’s (TRU) Earnings Growth Will Pick Up?

Corebridge Financial Launches New Multi-Year Guaranteed Annuity for Registered Investment Advisors
ROIV

Business Wire

2 years ago

Corebridge Financial Launches New Multi-Year Guaranteed Annuity for Registered Investment Advisors

FLT vs. V: Which Stock Is the Better Value Option?
ROIV

Zacks

2 years ago

FLT vs. V: Which Stock Is the Better Value Option?

Fight Ledger Failure with New Trex® Seal™ Sub-Ledger Tape
ROIV

GlobeNewswire

2 years ago

Fight Ledger Failure with New Trex® Seal™ Sub-Ledger Tape

Stride (LRN) to Report Q2 Earnings: Here's What to Expect
ROIV

Zacks

2 years ago

Stride (LRN) to Report Q2 Earnings: Here's What to Expect

HCMLY vs. MAS: Which Stock Is the Better Value Option?
ROIV

Zacks

2 years ago

HCMLY vs. MAS: Which Stock Is the Better Value Option?

Here's What Makes Carter's (CRI) Poised for Growth in 2024
ROIV

Zacks

2 years ago

Here's What Makes Carter's (CRI) Poised for Growth in 2024

Share on Social Networks: